Rhythm Pharmaceuticals, Inc.
RYTM
$90.51
$3.133.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 388.95M | 416.05M | 291.03M | 314.49M | 320.57M |
| Total Receivables | 26.08M | 33.03M | 26.12M | 17.83M | 18.51M |
| Inventory | 25.75M | 22.11M | 18.87M | 19.32M | 18.74M |
| Prepaid Expenses | -- | 23.61M | 24.66M | 17.66M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 26.13M | -- | -- | -- | 16.38M |
| Total Current Assets | 466.92M | 494.80M | 360.68M | 369.29M | 374.20M |
|
|
|||||
| Total Current Assets | 466.92M | 494.80M | 360.68M | 369.29M | 374.20M |
| Net Property, Plant & Equipment | 4.15M | 3.40M | 3.56M | 3.83M | 4.11M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.32M | 5.53M | 5.75M | 5.96M | 6.17M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.81M | 3.14M | 2.75M | 7.61M | 7.79M |
| Total Assets | 480.20M | 506.87M | 372.73M | 386.69M | 392.27M |
|
|
|||||
| Total Accounts Payable | 13.95M | 13.63M | 15.98M | 11.91M | 12.33M |
| Total Accrued Expenses | 79.78M | 81.06M | 64.81M | 53.51M | 58.31M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.95M | 6.18M | 4.29M | 1.81M | 1.54M |
| Total Finance Division Other Current Liabilities | 4.27M | 3.40M | 44.38M | 44.58M | 43.34M |
| Total Other Current Liabilities | 4.27M | 3.40M | 44.38M | 44.58M | 43.34M |
| Total Current Liabilities | 105.94M | 104.27M | 129.46M | 111.82M | 115.52M |
|
|
|||||
| Total Current Liabilities | 105.94M | 104.27M | 129.46M | 111.82M | 115.52M |
| Long-Term Debt | 100.89M | 103.41M | 106.01M | 107.93M | 108.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.34M | 3.52M | 3.68M | 3.84M | 3.94M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 210.17M | 211.19M | 239.15M | 223.60M | 227.72M |
|
|
|||||
| Common Stock & APIC | 1.49B | 1.45B | 1.24B | 1.22B | 1.18B |
| Retained Earnings | -1.35B | -1.30B | -1.25B | -1.20B | -1.16B |
| Treasury Stock & Other | -796.00K | -926.00K | -2.25M | -51.00K | -39.00K |
| Total Common Equity | 139.07M | 148.82M | -11.91M | 18.95M | 21.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 130.96M | 146.87M | 145.49M | 144.14M | 142.82M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 130.96M | 146.87M | 145.49M | 144.14M | 142.82M |
|
|
|||||
| Total Common Equity | 139.07M | 148.82M | -11.91M | 18.95M | 21.73M |
| Total Preferred Equity | 130.96M | 146.87M | 145.49M | 144.14M | 142.82M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 270.03M | 295.68M | 133.58M | 163.09M | 164.55M |
|
|
|||||